Lv42
480 积分 2023-09-29 加入
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
21天前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
1个月前
已完结
Myeloid-derived suppressor cells in cancer and cancer therapy
2个月前
已完结
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer
4个月前
已完结
Consolidation ALK Tyrosine Kinase Inhibitors versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK+ Non-Small Cell Lung Cancer
9个月前
已完结
Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-mutant non-small cell lung cancer (NORA)
9个月前
已完结
Lazertinib for patients with NSCLC harboring uncommon EGFR mutations: A phase II multi-center trial
9个月前
已完结
A pooled analysis of datopotamab deruxtecan in patients with EGFR–mutated NSCLC
9个月前
已完结
Amivantamab in Participants with Advanced Non-small Cell Lung Cancer (NSCLC) and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study
9个月前
已完结
Brief Report: Preventing Infusion-related Reactions With Intravenous Amivantamab: Results From SKIPPirr, a Phase 2 Study
9个月前
已完结
皖公网安备34019202002308
